Cerebrospinal fluid biomarkers and clinical features in leucine‐rich repeat kinase 2 (LRRK2) mutation carriers.. Mov Disord.; doi: 10.1002/mds.26591.. Dolores Vilas, Leslie M. Shaw, Peggy Taylor, Daniela Berg, Kathrin Brockmann, Jan Aasly, Connie Marras, Claustre Pont‐Sunyer, José Ríos, Ken Marek, Eduardo Tolosa (2015)
Mov Disord.; doi: 10.1002/mds.26591..
